APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary & Animal Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Veterinary & Animal Vaccines Industry Growth and Trends Forecast to 2032

20 December 2025107 pages

Choose your research edition.

Industry ResearchVeterinary & Animal Vaccines Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary & Animal Vaccines Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Veterinary & Animal Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary & Animal Vaccines Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary & Animal Vaccines Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Veterinary & Animal Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Veterinary & Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Veterinary & Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary & Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Veterinary & Animal Vaccines include Zoetis, Tianjin Ringpu, Merck Animal Health, Virbac, Vetoquinol, Phibro Animal Health, Idt Biologika, Hipra and Hester, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Veterinary & Animal Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Veterinary & Animal Vaccines market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Veterinary & Animal Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Veterinary & Animal Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Veterinary & Animal Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Veterinary & Animal Vaccines Market by Company

Zoetis

Tianjin Ringpu

Merck Animal Health

Virbac

Vetoquinol

Phibro Animal Health

Idt Biologika

Hipra

Hester

Elanco

China Animal Husbandry

Boehringer Ingelheim

Biogenesis Bago

Veterinary & Animal Vaccines Segment by Type

Live Attenuated Vaccines

Toxoid Vaccines

Inactivated Vaccines

Recombinant Vaccines

Other Vaccines

Veterinary & Animal Vaccines Segment by Application

Hospitals and Clinics

Others

Veterinary & Animal Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary & Animal Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary & Animal Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary & Animal Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Veterinary & Animal Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Veterinary & Animal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Live Attenuated Vaccines Table 2. Major Company of Toxoid Vaccines Table 3. Major Company of Inactivated Vaccines Table 4. Major Company of Recombinant Vaccines Table 5. Major Company of Other Vaccines Table 6. Global Veterinary & Animal Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Veterinary & Animal Vaccines Sales by Type (2021-2026) & (K Units) Table 8. Global Veterinary & Animal Vaccines Sales Market Share in Volume by Type (2021-2026) Table 9. Global Veterinary & Animal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 10. Global Veterinary & Animal Vaccines Sales Market Share in Value by Type (2021-2026) Table 11. Global Veterinary & Animal Vaccines Price by Type (2021-2026) & (US$/Unit) Table 12. Global Veterinary & Animal Vaccines Sales by Type (2027-2032) & (K Units) Table 13. Global Veterinary & Animal Vaccines Sales Market Share in Volume by Type (2027-2032) Table 14. Global Veterinary & Animal Vaccines Sales by Type (2027-2032) & (US$ Million) Table 15. Global Veterinary & Animal Vaccines Sales Market Share in Value by Type (2027-2032) Table 16. Global Veterinary & Animal Vaccines Price by Type (2027-2032) & (US$/Unit) Table 17. North America Veterinary & Animal Vaccines Sales by Type (2021-2026) & (K Units) Table 18. North America Veterinary & Animal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Veterinary & Animal Vaccines Sales by Type (2021-2026) & (K Units) Table 20. Europe Veterinary & Animal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Veterinary & Animal Vaccines Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Veterinary & Animal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Veterinary & Animal Vaccines Sales by Type (2021-2026) & (K Units) Table 24. Latin America Veterinary & Animal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Veterinary & Animal Vaccines Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Veterinary & Animal Vaccines Sales by Type (2021-2026) & (US$ Million) Table 27. Veterinary & Animal Vaccines Industry Trends Table 28. Veterinary & Animal Vaccines Industry Drivers Table 29. Veterinary & Animal Vaccines Industry Opportunities and Challenges Table 30. Veterinary & Animal Vaccines Industry Restraints Table 31. Global Veterinary & Animal Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Veterinary & Animal Vaccines Revenue Market Share by Company (2021-2026) Table 33. Global Veterinary & Animal Vaccines Sales by Company (2021-2026) & (K Units) Table 34. Global Veterinary & Animal Vaccines Sales Share by Company (2021-2026) Table 35. Global Veterinary & Animal Vaccines Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Veterinary & Animal Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Veterinary & Animal Vaccines Major Company Production Sites and Headquarters Table 38. Global Veterinary & Animal Vaccines Company, Product Type & Application Table 39. Global Veterinary & Animal Vaccines Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Veterinary & Animal Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Veterinary & Animal Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Veterinary & Animal Vaccines Sales by Region (2021-2026) & (K Units) Table 44. Global Veterinary & Animal Vaccines Sales Market Share in Volume by Region (2021-2026) Table 45. Global Veterinary & Animal Vaccines Sales by Region (2021-2026) & (US$ Million) Table 46. Global Veterinary & Animal Vaccines Sales Market Share in Value by Region (2021-2026) Table 47. Global Veterinary & Animal Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Veterinary & Animal Vaccines Sales by Region (2027-2032) & (K Units) Table 49. Global Veterinary & Animal Vaccines Sales Market Share in Volume by Region (2027-2032) Table 50. Global Veterinary & Animal Vaccines Sales by Region (2027-2032) & (US$ Million) Table 51. Global Veterinary & Animal Vaccines Sales Market Share in Value by Region (2027-2032) Table 52. Global Veterinary & Animal Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Veterinary & Animal Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Veterinary & Animal Vaccines Sales by Application (2021-2026) & (K Units) Table 55. Global Veterinary & Animal Vaccines Sales Market Share in Volume by Application (2021-2026) Table 56. Global Veterinary & Animal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 57. Global Veterinary & Animal Vaccines Sales Market Share in Value by Application (2021-2026) Table 58. Global Veterinary & Animal Vaccines Price by Application (2021-2026) & (US$/Unit) Table 59. Global Veterinary & Animal Vaccines Sales by Application (2027-2032) & (K Units) Table 60. Global Veterinary & Animal Vaccines Sales Market Share in Volume by Application (2027-2032) Table 61. Global Veterinary & Animal Vaccines Sales by Application (2027-2032) & (US$ Million) Table 62. Global Veterinary & Animal Vaccines Sales Market Share in Value by Application (2027-2032) Table 63. Global Veterinary & Animal Vaccines Price by Application (2027-2032) & (US$/Unit) Table 64. North America Veterinary & Animal Vaccines Sales by Application (2021-2026) & (K Units) Table 65. North America Veterinary & Animal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Veterinary & Animal Vaccines Sales by Application (2021-2026) & (K Units) Table 67. Europe Veterinary & Animal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Veterinary & Animal Vaccines Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Veterinary & Animal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Veterinary & Animal Vaccines Sales by Application (2021-2026) & (K Units) Table 71. Latin America Veterinary & Animal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Veterinary & Animal Vaccines Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Veterinary & Animal Vaccines Sales by Application (2021-2026) & (US$ Million) Table 74. Zoetis Company Information Table 75. Zoetis Business Overview Table 76. Zoetis Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Zoetis Veterinary & Animal Vaccines Product Portfolio Table 78. Zoetis Recent Development Table 79. Tianjin Ringpu Company Information Table 80. Tianjin Ringpu Business Overview Table 81. Tianjin Ringpu Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Tianjin Ringpu Veterinary & Animal Vaccines Product Portfolio Table 83. Tianjin Ringpu Recent Development Table 84. Merck Animal Health Company Information Table 85. Merck Animal Health Business Overview Table 86. Merck Animal Health Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Merck Animal Health Veterinary & Animal Vaccines Product Portfolio Table 88. Merck Animal Health Recent Development Table 89. Virbac Company Information Table 90. Virbac Business Overview Table 91. Virbac Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Virbac Veterinary & Animal Vaccines Product Portfolio Table 93. Virbac Recent Development Table 94. Vetoquinol Company Information Table 95. Vetoquinol Business Overview Table 96. Vetoquinol Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Vetoquinol Veterinary & Animal Vaccines Product Portfolio Table 98. Vetoquinol Recent Development Table 99. Phibro Animal Health Company Information Table 100. Phibro Animal Health Business Overview Table 101. Phibro Animal Health Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Phibro Animal Health Veterinary & Animal Vaccines Product Portfolio Table 103. Phibro Animal Health Recent Development Table 104. Idt Biologika Company Information Table 105. Idt Biologika Business Overview Table 106. Idt Biologika Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Idt Biologika Veterinary & Animal Vaccines Product Portfolio Table 108. Idt Biologika Recent Development Table 109. Hipra Company Information Table 110. Hipra Business Overview Table 111. Hipra Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Hipra Veterinary & Animal Vaccines Product Portfolio Table 113. Hipra Recent Development Table 114. Hester Company Information Table 115. Hester Business Overview Table 116. Hester Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Hester Veterinary & Animal Vaccines Product Portfolio Table 118. Hester Recent Development Table 119. Elanco Company Information Table 120. Elanco Business Overview Table 121. Elanco Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Elanco Veterinary & Animal Vaccines Product Portfolio Table 123. Elanco Recent Development Table 124. China Animal Husbandry Company Information Table 125. China Animal Husbandry Business Overview Table 126. China Animal Husbandry Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. China Animal Husbandry Veterinary & Animal Vaccines Product Portfolio Table 128. China Animal Husbandry Recent Development Table 129. Boehringer Ingelheim Company Information Table 130. Boehringer Ingelheim Business Overview Table 131. Boehringer Ingelheim Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Boehringer Ingelheim Veterinary & Animal Vaccines Product Portfolio Table 133. Boehringer Ingelheim Recent Development Table 134. Biogenesis Bago Company Information Table 135. Biogenesis Bago Business Overview Table 136. Biogenesis Bago Veterinary & Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Biogenesis Bago Veterinary & Animal Vaccines Product Portfolio Table 138. Biogenesis Bago Recent Development Table 139. North America Veterinary & Animal Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. North America Veterinary & Animal Vaccines Sales by Country (2021-2026) & (K Units) Table 141. North America Veterinary & Animal Vaccines Sales Market Share by Country (2021-2026) Table 142. North America Veterinary & Animal Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 143. North America Veterinary & Animal Vaccines Sales Market Share Forecast by Country (2027-2032) Table 144. North America Veterinary & Animal Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. North America Veterinary & Animal Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 146. North America Veterinary & Animal Vaccines Market Share by Country (2021-2026) Table 147. North America Veterinary & Animal Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. North America Veterinary & Animal Vaccines Market Share Forecast by Country (2027-2032) Table 149. Europe Veterinary & Animal Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. Europe Veterinary & Animal Vaccines Sales by Country (2021-2026) & (K Units) Table 151. Europe Veterinary & Animal Vaccines Sales Market Share by Country (2021-2026) Table 152. Europe Veterinary & Animal Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 153. Europe Veterinary & Animal Vaccines Sales Market Share Forecast by Country (2027-2032) Table 154. Europe Veterinary & Animal Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Europe Veterinary & Animal Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 156. Europe Veterinary & Animal Vaccines Market Share by Country (2021-2026) Table 157. Europe Veterinary & Animal Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Europe Veterinary & Animal Vaccines Market Share Forecast by Country (2027-2032) Table 159. Asia-Pacific Veterinary & Animal Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 160. Asia-Pacific Veterinary & Animal Vaccines Sales by Country (2021-2026) & (K Units) Table 161. Asia-Pacific Veterinary & Animal Vaccines Sales Market Share by Country (2021-2026) Table 162. Asia-Pacific Veterinary & Animal Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 163. Asia-Pacific Veterinary & Animal Vaccines Sales Market Share Forecast by Country (2027-2032) Table 164. Asia-Pacific Veterinary & Animal Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Asia-Pacific Veterinary & Animal Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 166. Asia-Pacific Veterinary & Animal Vaccines Market Share by Country (2021-2026) Table 167. Asia-Pacific Veterinary & Animal Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Asia-Pacific Veterinary & Animal Vaccines Market Share Forecast by Country (2027-2032) Table 169. Latin America Veterinary & Animal Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 170. Latin America Veterinary & Animal Vaccines Sales by Country (2021-2026) & (K Units) Table 171. Latin America Veterinary & Animal Vaccines Sales Market Share by Country (2021-2026) Table 172. Latin America Veterinary & Animal Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 173. Latin America Veterinary & Animal Vaccines Sales Market Share Forecast by Country (2027-2032) Table 174. Latin America Veterinary & Animal Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Latin America Veterinary & Animal Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 176. Latin America Veterinary & Animal Vaccines Market Share by Country (2021-2026) Table 177. Latin America Veterinary & Animal Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Latin America Veterinary & Animal Vaccines Market Share Forecast by Country (2027-2032) Table 179. Middle East and Africa Veterinary & Animal Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 180. Middle East and Africa Veterinary & Animal Vaccines Sales by Country (2021-2026) & (K Units) Table 181. Middle East and Africa Veterinary & Animal Vaccines Sales Market Share by Country (2021-2026) Table 182. Middle East and Africa Veterinary & Animal Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 183. Middle East and Africa Veterinary & Animal Vaccines Sales Market Share Forecast by Country (2027-2032) Table 184. Middle East and Africa Veterinary & Animal Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 185. Middle East and Africa Veterinary & Animal Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 186. Middle East and Africa Veterinary & Animal Vaccines Market Share by Country (2021-2026) Table 187. Middle East and Africa Veterinary & Animal Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 188. Middle East and Africa Veterinary & Animal Vaccines Market Share Forecast by Country (2027-2032) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Veterinary & Animal Vaccines Distributors List Table 192. Veterinary & Animal Vaccines Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Veterinary & Animal Vaccines Image Figure 2. Global Veterinary & Animal Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary & Animal Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary & Animal Vaccines Sales (2021-2032) & (K Units) Figure 5. Live Attenuated Vaccines Image Figure 6. Global Live Attenuated Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 7. Toxoid Vaccines Image Figure 8. Global Toxoid Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 9. Inactivated Vaccines Image Figure 10. Global Inactivated Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 11. Recombinant Vaccines Image Figure 12. Global Recombinant Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 13. Other Vaccines Image Figure 14. Global Other Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Veterinary & Animal Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Veterinary & Animal Vaccines Market Share by Type 2025 VS 2032 Figure 17. North America Veterinary & Animal Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. North America Veterinary & Animal Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Europe Veterinary & Animal Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Europe Veterinary & Animal Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Veterinary & Animal Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Veterinary & Animal Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Latin America Veterinary & Animal Vaccines Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Veterinary & Animal Vaccines Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Veterinary & Animal Vaccines Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Veterinary & Animal Vaccines Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Veterinary & Animal Vaccines Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospitals and Clinics Image Figure 30. Global Hospitals and Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Veterinary & Animal Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Veterinary & Animal Vaccines Market Share by Application 2025 VS 2032 Figure 35. North America Veterinary & Animal Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. North America Veterinary & Animal Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Europe Veterinary & Animal Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Europe Veterinary & Animal Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Veterinary & Animal Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Veterinary & Animal Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Latin America Veterinary & Animal Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Veterinary & Animal Vaccines Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Veterinary & Animal Vaccines Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Veterinary & Animal Vaccines Sales Market Share in Value by Application in 2025 Figure 45. North America Veterinary & Animal Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Veterinary & Animal Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Veterinary & Animal Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Veterinary & Animal Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Veterinary & Animal Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Veterinary & Animal Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Veterinary & Animal Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Veterinary & Animal Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Veterinary & Animal Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Veterinary & Animal Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Veterinary & Animal Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Veterinary & Animal Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Veterinary & Animal Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Veterinary & Animal Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Veterinary & Animal Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Veterinary & Animal Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Veterinary & Animal Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Veterinary & Animal Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Veterinary & Animal Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Veterinary & Animal Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Veterinary & Animal Vaccines Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Veterinary & Animal Vaccines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Live Attenuated Vaccines
  • Toxoid Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines
  • Other Vaccines
Applications
  • Hospitals and Clinics
  • Others
Companies covered
  • Zoetis
  • Tianjin Ringpu
  • Merck Animal Health
  • Virbac
  • Vetoquinol
  • Phibro Animal Health
  • Idt Biologika
  • Hipra
  • Hester
  • Elanco
  • China Animal Husbandry
  • Boehringer Ingelheim
  • Biogenesis Bago

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary & Animal Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Veterinary & Animal Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Veterinary & Animal Vaccines Market by Type
  6. 1.3.1 Live Attenuated Vaccines
  7. 1.3.2 Toxoid Vaccines
  8. 1.3.3 Inactivated Vaccines
  9. 1.3.4 Recombinant Vaccines
  10. 1.3.5 Other Vaccines
  11. 1.4 Global Veterinary & Animal Vaccines Market Size by Type
  12. 1.4.1 Global Veterinary & Animal Vaccines Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Veterinary & Animal Vaccines Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Veterinary & Animal Vaccines Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Veterinary & Animal Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Veterinary & Animal Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Veterinary & Animal Vaccines Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Veterinary & Animal Vaccines Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Veterinary & Animal Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Veterinary & Animal Vaccines Industry Trends
  2. 2.2 Veterinary & Animal Vaccines Industry Drivers
  3. 2.3 Veterinary & Animal Vaccines Industry Opportunities and Challenges
  4. 2.4 Veterinary & Animal Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Veterinary & Animal Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Veterinary & Animal Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Veterinary & Animal Vaccines Price (2021-2026)
  4. 3.4 Global Veterinary & Animal Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Veterinary & Animal Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Veterinary & Animal Vaccines Company, Product Type & Application
  7. 3.7 Global Veterinary & Animal Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Veterinary & Animal Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Veterinary & Animal Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Veterinary & Animal Vaccines Tier 1, Tier 2, and Tier 3
4 Veterinary & Animal Vaccines Regional Status and Outlook
  1. 4.1 Global Veterinary & Animal Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Veterinary & Animal Vaccines Historic Market Size by Region
  3. 4.2.1 Global Veterinary & Animal Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Veterinary & Animal Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Veterinary & Animal Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Veterinary & Animal Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Veterinary & Animal Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Veterinary & Animal Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Veterinary & Animal Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Veterinary & Animal Vaccines by Application
  1. 5.1 Veterinary & Animal Vaccines Market by Application
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Others
  4. 5.2 Global Veterinary & Animal Vaccines Market Size by Application
  5. 5.2.1 Global Veterinary & Animal Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Veterinary & Animal Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Veterinary & Animal Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Veterinary & Animal Vaccines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Veterinary & Animal Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Veterinary & Animal Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Veterinary & Animal Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Veterinary & Animal Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zoetis
  2. 6.1.1 Zoetis Company Information
  3. 6.1.2 Zoetis Business Overview
  4. 6.1.3 Zoetis Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zoetis Veterinary & Animal Vaccines Product Portfolio
  6. 6.1.5 Zoetis Recent Developments
  7. 6.2 Tianjin Ringpu
  8. 6.2.1 Tianjin Ringpu Company Information
  9. 6.2.2 Tianjin Ringpu Business Overview
  10. 6.2.3 Tianjin Ringpu Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Tianjin Ringpu Veterinary & Animal Vaccines Product Portfolio
  12. 6.2.5 Tianjin Ringpu Recent Developments
  13. 6.3 Merck Animal Health
  14. 6.3.1 Merck Animal Health Company Information
  15. 6.3.2 Merck Animal Health Business Overview
  16. 6.3.3 Merck Animal Health Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Animal Health Veterinary & Animal Vaccines Product Portfolio
  18. 6.3.5 Merck Animal Health Recent Developments
  19. 6.4 Virbac
  20. 6.4.1 Virbac Company Information
  21. 6.4.2 Virbac Business Overview
  22. 6.4.3 Virbac Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Virbac Veterinary & Animal Vaccines Product Portfolio
  24. 6.4.5 Virbac Recent Developments
  25. 6.5 Vetoquinol
  26. 6.5.1 Vetoquinol Company Information
  27. 6.5.2 Vetoquinol Business Overview
  28. 6.5.3 Vetoquinol Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Vetoquinol Veterinary & Animal Vaccines Product Portfolio
  30. 6.5.5 Vetoquinol Recent Developments
  31. 6.6 Phibro Animal Health
  32. 6.6.1 Phibro Animal Health Company Information
  33. 6.6.2 Phibro Animal Health Business Overview
  34. 6.6.3 Phibro Animal Health Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Phibro Animal Health Veterinary & Animal Vaccines Product Portfolio
  36. 6.6.5 Phibro Animal Health Recent Developments
  37. 6.7 Idt Biologika
  38. 6.7.1 Idt Biologika Company Information
  39. 6.7.2 Idt Biologika Business Overview
  40. 6.7.3 Idt Biologika Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Idt Biologika Veterinary & Animal Vaccines Product Portfolio
  42. 6.7.5 Idt Biologika Recent Developments
  43. 6.8 Hipra
  44. 6.8.1 Hipra Company Information
  45. 6.8.2 Hipra Business Overview
  46. 6.8.3 Hipra Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hipra Veterinary & Animal Vaccines Product Portfolio
  48. 6.8.5 Hipra Recent Developments
  49. 6.9 Hester
  50. 6.9.1 Hester Company Information
  51. 6.9.2 Hester Business Overview
  52. 6.9.3 Hester Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hester Veterinary & Animal Vaccines Product Portfolio
  54. 6.9.5 Hester Recent Developments
  55. 6.10 Elanco
  56. 6.10.1 Elanco Company Information
  57. 6.10.2 Elanco Business Overview
  58. 6.10.3 Elanco Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Elanco Veterinary & Animal Vaccines Product Portfolio
  60. 6.10.5 Elanco Recent Developments
  61. 6.11 China Animal Husbandry
  62. 6.11.1 China Animal Husbandry Company Information
  63. 6.11.2 China Animal Husbandry Business Overview
  64. 6.11.3 China Animal Husbandry Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 China Animal Husbandry Veterinary & Animal Vaccines Product Portfolio
  66. 6.11.5 China Animal Husbandry Recent Developments
  67. 6.12 Boehringer Ingelheim
  68. 6.12.1 Boehringer Ingelheim Company Information
  69. 6.12.2 Boehringer Ingelheim Business Overview
  70. 6.12.3 Boehringer Ingelheim Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Boehringer Ingelheim Veterinary & Animal Vaccines Product Portfolio
  72. 6.12.5 Boehringer Ingelheim Recent Developments
  73. 6.13 Biogenesis Bago
  74. 6.13.1 Biogenesis Bago Company Information
  75. 6.13.2 Biogenesis Bago Business Overview
  76. 6.13.3 Biogenesis Bago Veterinary & Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Biogenesis Bago Veterinary & Animal Vaccines Product Portfolio
  78. 6.13.5 Biogenesis Bago Recent Developments
7 North America by Country
  1. 7.1 North America Veterinary & Animal Vaccines Sales by Country
  2. 7.1.1 North America Veterinary & Animal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Veterinary & Animal Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Veterinary & Animal Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Veterinary & Animal Vaccines Market Size by Country
  6. 7.2.1 North America Veterinary & Animal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Veterinary & Animal Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Veterinary & Animal Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Veterinary & Animal Vaccines Sales by Country
  2. 8.1.1 Europe Veterinary & Animal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Veterinary & Animal Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Veterinary & Animal Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Veterinary & Animal Vaccines Market Size by Country
  6. 8.2.1 Europe Veterinary & Animal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Veterinary & Animal Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Veterinary & Animal Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Veterinary & Animal Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Veterinary & Animal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Veterinary & Animal Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Veterinary & Animal Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Veterinary & Animal Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Veterinary & Animal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Veterinary & Animal Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Veterinary & Animal Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Veterinary & Animal Vaccines Sales by Country
  2. 10.1.1 South America Veterinary & Animal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Veterinary & Animal Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Veterinary & Animal Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Veterinary & Animal Vaccines Market Size by Country
  6. 10.2.1 South America Veterinary & Animal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Veterinary & Animal Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Veterinary & Animal Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Veterinary & Animal Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Veterinary & Animal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Veterinary & Animal Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Veterinary & Animal Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Veterinary & Animal Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Veterinary & Animal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Veterinary & Animal Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Veterinary & Animal Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Veterinary & Animal Vaccines Value Chain Analysis
  2. 12.1.1 Veterinary & Animal Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Veterinary & Animal Vaccines Production Mode & Process
  7. 12.2 Veterinary & Animal Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Veterinary & Animal Vaccines Distributors
  10. 12.2.3 Veterinary & Animal Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst